Pan-Canadian Oncology Drug Review Final Economic Guidance Report : Blinatumomab (Blincyto) for Pediatric AcuteLymphoblastic Leukemia. (eBook, 2017) [WorldCat.org]
skip to content
Pan-Canadian Oncology Drug Review Final Economic Guidance Report : Blinatumomab (Blincyto) for Pediatric AcuteLymphoblastic Leukemia.
Checking...

Pan-Canadian Oncology Drug Review Final Economic Guidance Report : Blinatumomab (Blincyto) for Pediatric AcuteLymphoblastic Leukemia.

Publisher: Ottawa, ON, CA : Canadian Agency for Drugs and Technologies in Health, 2017.
Series: Canadian Agency for Drugs and Technologies in Health
Edition/Format:   eBook : Document : English
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
OCLC Number: 1002119011
Description: 1 online resource (13 pages)
Series Title: Canadian Agency for Drugs and Technologies in Health
More information:

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.